By stimulating myeloid-derived suppressor cells, regulatory T-cells and tumor-associated macrophages, VEGF was also shown to mediate an immunosuppressive tumor microenvironment (TME) and, thereby, HCC progression and metastasis [25]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.